Tofacitinib Tablet, Film Coated
Product Images NDC 42571-377

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tofacitinib (NDC 42571-377). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tofacitinib-fig1 (Tofacitinib Fig1)

FDA Label Image

Tofacitinib-fig2.jpg (Tofacitinib Fig2)

This text appears to be a table showing information related to the coadministration of PK drugs, including the netorexae AUC, contraceptives, and MATE substrate Nitormin. The table also includes ratios and 90% confidence intervals.*

FDA Label Image

Tofacitinib-fig3 (Tofacitinib Fig3)

This is a table showing the concentration ratios and 90% confidence intervals for different drugs such as CYPMA, Cyclosporine A, Metorenste A, and Tocolms AC. The data includes values for Cmax and Cpmdce.*

FDA Label Image

Tofacitinib-fig4.jpg (Tofacitinib Fig4)

This text provides information about response rates and imputation methods used in a study. Non-responder imputation was employed, counting withdrawn patients and those who did not show at least a 20% improvement in joint counts at Month 3 as failures.*

FDA Label Image

Tofacitinib-fig5.jpg (Tofacitinib Fig5)

FDA Label Image

Tofacitinib-fig6.jpg (Tofacitinib Fig6)

FDA Label Image

Tofacitinib-fig7.jpg (Tofacitinib Fig7)

FDA Label Image

Tofacitinib-lbl10mg.jpg (Tofacitinib Lbl10mg)

This text provides information about a medication containing Tofacitinib 10 mg, equivalent to 16.16 mg of Tofacitinib Citrate. The dosage and usage instructions are advised to be checked in the accompanying prescribing information. Storage instructions indicate a range of 20°C to 25°C with excursions permitted between 15°C and 30°C. The medication is specifically recommended for ulcerative colitis. The tablets are manufactured by Micro Labs Limited in Goa, India, and further details are specified for Micro Labs USA, Inc. based in Somerset, NJ. Additionally, the packaging offers 30 tablets.*

FDA Label Image

Tofacitinib-lbl5mg.jpg (Tofacitinib Lbl5mg)

Each tablet of the medication contains 5 mg of Tofacitinib (equivalent to 8 mg of Tofacitinib Citrate). The recommended dosage and use information can be found in the accompanying prescribing information. The tablets should be stored at a temperature range between 20°C to 25°C and excursions between 15°C and 30°C are permitted. The product comes in a pack of 30 tablets and each patient should receive a Medication Guide. It is advised not to repackage the tablets. The medication is manufactured by Micro Labs Limited in India and distributed by Micro Labs USA, Inc. located in Somerset, NJ.*

FDA Label Image

Tofacitinib-str.jpg (Tofacitinib Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.